Latest Market Risk News

Lake Resources has updated its lithium ore reserve for the Kachi Project in Argentina, unveiling an optimized mine plan that boosts lithium grades and recovery while cutting costs and environmental impact.

Duxton Water Limited has significantly reduced its debt and maintained steady dividends while navigating a challenging water market marked by dry conditions and rising lease yields.

Kuniko Limited has announced a $2.03 million pro-rata entitlement offer, issuing new shares and free options to existing shareholders to support its expansion in battery metals exploration and development in Norway.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

Australian Bond Exchange Holdings (ASX, ABE) reported a stronger Q4 FY25 with participation in a landmark digital currency pilot and the launch of an innovative AUD-denominated market-linked security, alongside improved cash flow and fresh capital raises.

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

DigitalX Limited reported a 32.8% increase in digital asset holdings to $72.9 million and raised $20.7 million to pivot its treasury strategy firmly towards Bitcoin. The DigitalX Bitcoin ETF (BTXX) also surged, nearing $53 million in assets under management.

AMCIL Limited reported a net profit of $6.7 million for FY2025, down from $7.5 million the previous year, and announced a fully franked total dividend of 6.5 cents per share, boosted by a special capital gains payout.

Matrix Composites & Engineering has landed a new A$10 million subsea buoyancy contract for a Gulf of Mexico project, adding to over A$45 million in awards this financial year and reinforcing its global SURF market presence.

Enlitic, Inc. has confirmed its commitment to achieving operational cashflow break-even by the end of 2025, alongside maintaining its revenue guidance of US$9-11 million for the calendar year.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir ahead of schedule, setting sights on expedited FDA approval leveraging the Animal Rule.

QX Resources reported steady progress in its Queensland gold projects and secured a strategic farm-out for its Pilbara iron ore rights, while stepping back from US lithium ventures amid market softness.